Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types
Yutong Chen(Sun Yat-sen University), Yu‐Pei Chen(Sun Yat-sen University), Jiayi Shen(Sun Yat-sen University), Wenfei Li(Lawrence Berkeley National Laboratory), Panpan Zhang(Sun Yat-sen University), Zixian Wang(Sun Yat-sen University), Rui Guo(Sun Yat-sen University), Dong‐Ping Chen(Guangzhou Medical University), Jia‐Wei Lv(Zhejiang Chinese Medical University), Chen‐Fei Wu(Sun Yat-sen University)
Cited by 75
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
|Cell Research|2020|483
Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3
|Cancer Research|2019|423
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
|The Lancet|2021|234
WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis
|Cell Death and Differentiation|2022|173